SLAM inhibitors, short for Signaling Lymphocyte Activation Molecule inhibitors, belong to a class of chemical compounds that primarily target the signaling pathways involved in immune cell activation and regulation. These inhibitors have garnered significant attention in the field of immunology due to their role in modulating immune responses. The SLAM family of proteins plays a pivotal role in immune cell communication and coordination. These proteins are primarily expressed on the surface of various immune cells, including T cells, B cells, natural killer (NK) cells, and dendritic cells, and are essential for the regulation of immune cell activation, proliferation, and effector functions.
SLAM inhibitors typically interfere with the interactions between SLAM family receptors and their ligands, which are crucial for the initiation of downstream signaling cascades. By inhibiting these interactions, SLAM inhibitors can disrupt the intricate network of cellular communication within the immune system. This disruption can lead to altered immune responses, making SLAM inhibitors valuable tools for studying immune cell behavior and immune-related diseases. Researchers have used SLAM inhibitors in various experimental settings to investigate the underlying mechanisms of immune cell activation and to gain insights into the complex interplay between different immune cell populations. Their role in dissecting immune pathways makes SLAM inhibitors an essential class of compounds for advancing our understanding of immunology and developing potential strategies for immune modulation
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride can inhibit the H+/Na+ exchange process, which may indirectly affect SLAMF1 signaling involved in T-cell activation and proliferation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a tyrosine kinase inhibitor that can inhibit Src family kinases, which are upstream regulators of SLAMF1-dependent signaling pathways in immune cells. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor that can suppress the activation of kinases involved in the signaling cascade of SLAMF1. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine can intercalate into cell membranes and modulate signaling pathways, indirectly affecting SLAMF1-mediated functions. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine stabilizes the neuronal membrane and can indirectly influence signal transduction pathways involving SLAMF1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can disrupt downstream signaling of SLAMF1, which is involved in the regulation of immune responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that can alter SLAMF1 downstream signaling pathways, affecting the immune cell functions. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib can inhibit certain tyrosine kinases, potentially affecting the upstream signaling that leads to SLAMF1 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can inhibit kinases associated with SLAMF1 signaling. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a V-ATPase inhibitor that can disrupt endosomal acidification, potentially affecting SLAMF1-mediated immune responses. | ||||||